%0 Journal Article %A Giopanou, Ioanna%A %A Pintzas, Alexandros %D 2020 %T RAS and BRAF in the foreground for non-small cell lung cancer and colorectal cancer: Similarities and main differences for prognosis and therapies: Review %J Critical reviews in oncology/hematology %V 146 %R 10.1016/j.critrevonc.2019.102859 %I Elsevier %P 102859 %U https://hdl.handle.net/10442/18093 %X Lung and colorectal cancer are included in the most tremendously threatening diseases in terms of incidence and death. Although they are located in completely different organs and differ in various characteristics they do share some common features, especially regarding their molecular mutational profile. Among several commonly mutated genes KRAS and BRAF are spotted to be highly associated with patient’s poor disease outcome and resistance to targeted therapies mostly in liaison with other mutant activated genes. Many studies have shed light in these mechanisms for disease progression and numerous preclinical models, clinical trials and meta-analysis reports investigate the impact of specific treatments or combination of therapies. The present review is an effort to compare the mutational imprint of these genes between the two diseases and their impact in prognosis, current therapy, mechanisms of therapy resistance and future therapeutic plans and provide a spherical perspective regarding the systemic molecular profile of cancer. %> Αποθετήριο Ήλιος / ΕΙΕ